Acute Effects of Moderate-Intensity Swimming Exercise on Inhibitory Control, Cognitive Flexibility, and Selective Attention (SWIMCOG)
Acute Effects of Moderate-Intensity Freestyle Swimming Exercise on Inhibitory Control, Cognitive Flexibility, and Selective Attention: A Randomized Controlled Trial
This randomized controlled trial aims to investigate the acute effects of a single session of moderate-intensity freestyle swimming exercise on cognitive performance in healthy young adults. Cognitive functions such as inhibitory control, selective attention, and cognitive flexibility are essential components of executive functioning and play an important role in academic, occupational, and daily activities.
A total of 60 healthy adults aged 18-35 years will be randomly assigned to either an exercise group or a control group. Participants in the exercise group will complete a 30-minute session of moderate-intensity freestyle swimming, while participants in the control group will undergo passive seated rest for the same duration.
Cognitive performance will be evaluated immediately before and after the intervention using the Eriksen Flanker Task and the Stroop Color-Word Test. These assessments measure reaction time, attention control, information processing speed, and inhibitory control.
The study is designed to determine whether a single bout of swimming exercise can produce immediate improvements in executive functions compared with passive rest. Findings from this research may contribute to a better understanding of the relationship between aerobic exercise and cognitive performance and may help inform exercise-based strategies for enhancing cognitive health and performance in healthy individuals.
Přehled studie
Postavení
Intervence / Léčba
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Istanbul
-
Istanbul, Istanbul, Turecko (Türkiye), 34290
- Istanbul Rumeli University, Faculty of Sport Sciences
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- Healthy adults aged 18 to 35 years.
- Normal or corrected-to-normal vision.
- Right-handed as determined by the Edinburgh Handedness Inventory.
- No history of neurological, psychiatric, or cardiovascular disorders.
- Engaging in structured exercise fewer than three times per week.
- Ability to safely participate in moderate-intensity swimming exercise.
- Provision of written informed consent.
Exclusion Criteria:
- Use of medications that may affect cognitive performance.
- Active musculoskeletal injury or pain limiting participation in exercise.
- Previous experience with the Eriksen Flanker Task or Stroop Color-Word Test.
- Contraindications to swimming exercise.
- Participation in vigorous physical activity within 24 hours before testing.
- Any medical condition considered unsafe for exercise participation by the investigators.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Základní věda
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Experimental Group
Participants assigned to the experimental group completed a single 30-minute session of moderate-intensity freestyle swimming exercise.
The exercise protocol included a 5-minute warm-up, 20 minutes of continuous swimming at moderate intensity (approximately 60-70% of age-predicted maximum heart rate), and a 5-minute cool-down period.
|
A single session of moderate-intensity freestyle swimming lasting 30 minutes.
The protocol consisted of a 5-minute warm-up, 20 minutes of continuous freestyle swimming performed at approximately 60-70% of age-predicted maximum heart rate, and a 5-minute cool-down.
Exercise intensity was monitored using ratings of perceived exertion and heart rate measurements.
|
|
Žádný zásah: Control Group
Participants assigned to the control group remained seated at rest for 30 minutes in a quiet environment.
During this period, participants were instructed to avoid physical activity and cognitive stimulation.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Congruent Flanker Task Reaction Time
Časové okno: Immediately before and immediately after the 30-minute intervention session
|
Mean reaction time during congruent trials of the Eriksen Flanker Task.
|
Immediately before and immediately after the 30-minute intervention session
|
|
Incongruent Flanker Task Reaction Time
Časové okno: Immediately before and immediately after the 30-minute intervention session
|
Mean reaction time during incongruent trials of the Eriksen Flanker Task.
|
Immediately before and immediately after the 30-minute intervention session
|
|
Stroop Test Completion Time
Časové okno: Immediately before and immediately after the 30-minute intervention session
|
Total completion time across the Stroop Color-Word Test (TBAG Form), assessing inhibitory control, selective attention, and cognitive flexibility.
|
Immediately before and immediately after the 30-minute intervention session
|
Spolupracovníci a vyšetřovatelé
Sponzor
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další identifikační čísla studie
- IRU-2026
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Výkonná funkce
-
Incyte CorporationDostupnýSTAT1 Gain-of-Function Disease
-
Faeth TherapeuticsUkončenoPokročilý pevný nádor | Mutace PIK3CA | PTEN Loss of Function MutationSpojené státy